Patient is a 56-year-old female who is planning to have surgery for a gallbladder removal due to chronic cholecystitis.

Her medical history includes hypertension, hyperlipidemia, and type 2 diabetes mellitus diagnosed 10 years ago.

She has been managed on antihypertensive medications and a statin for her hyperlipidemia, which is well-controlled.

For her diabetes, the patient has been on metformin 1000 mg twice daily and has achieved good glycemic control with an HbA1c level of 6.8%.

She has no known drug allergies.

Her baseline renal function is normal, with a serum creatinine of 0.8 mg/dL.

She does not have any known respiratory conditions, such as asthma or chronic obstructive pulmonary disease.

The patient is a non-smoker and does not consume alcohol regularly.

Her preoperative fasting blood glucose and lipid profiles were within normal limits.

Her preoperative electrocardiogram shows sinus rhythm with no evidence of ischemia or arrhythmias.

She underwent a preoperative anesthesia evaluation and was found to be fit for surgery.

The patient is aware of the risks and benefits of the surgery and has provided informed consent.

She has undergone a preoperative counseling session with the surgeon, discussing the procedure in detail.

The patient has been advised to discontinue her metformin 48 hours before the surgery and has been given instructions for managing her blood glucose levels using short-acting insulin.

The surgery is scheduled to be performed laparoscopically and is expected to be straightforward without any anticipated complications.

The patient was admitted to the hospital on the day of the surgery and was started on prophylactic antibiotics.

Intraoperatively, the surgery proceeded uneventfully, and the gallbladder was successfully removed.

The patient was extubated in the operating room and transferred to the post-anesthesia care unit for monitoring.

She had a smooth recovery in the immediate postoperative period, with stable vital signs and no signs of surgical site infection.

The patient was started on a clear liquid diet on postoperative day 1 and tolerated it well.

Her pain was adequately managed with the use of non-opioid analgesics.

Throughout her hospital stay, the patient received appropriate deep vein thrombosis prophylaxis.

She was closely monitored for any signs of postoperative complications, including infection, bleeding, or bile leakage.

On postoperative day 2, the patient's incision sites were clean and healing well.

She met all the discharge criteria and was ready for discharge on postoperative day 3.

The patient was provided with written and verbal instructions regarding wound care and follow-up appointments.

She did not experience any postoperative complications and was advised to schedule a follow-up visit with her surgeon in two weeks to assess her surgical wound and overall recovery.